The pharma will pay $800 million for the biotech, which was launched nearly two decades ago by Alnylam and Ionis to advance ...

Comprehensive overview of lupus in India, symptoms, treatment, and challenges faced in diagnosis and management.

Novartis has committed another $1.7 billion to its ambition to become a kidney disease leader. The Swiss drugmaker is making ...

Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental ...

Orphan drug specialist Amicus Therapeutics is paying Dimerix $30 million cash for U.S. rights to the phase 3 prospect DMX-200 ...

Kidney disease is a serious yet often overlooked condition that affects millions worldwide. Despite its impact, it is frequently underestimated compared to illnesses like cancer and heart disease.

Itchy skin is a common symptom of kidney disease, especially in the later stages ... In 2021, the Food and Drug Administration (FDA) approved a drug to treat moderate to severe itching in people ...